Post Malone issues apology to fans over lengthy wait for new album – Music News
Post Malone has apologised to fans for the wait for his next album. The Circles hitmaker has been…
The Rolling Stones have five new songs coming out as Foreign Tongues gets expanded – Music News
The Rolling Stones are set to drop five new songs on Foreign Tongues, Loose Lips, the deluxe edition…
A Father Used Muse to Prep His Son for a Quiz. He Aced It.
This as-told-to essay is based on a conversation with Franco Lopez, a 53-year-old from Miami who works in…
Elon Musk: SpaceX Could Be Worth Vastly More Than Earth’s Economy
Elon Musk is known for having planet-sized ambitions, and his latest pronouncement lives up to that billing. “This…
Amazon Layoffs Hit Hundreds of Employees Across Multiple Teams
Amazon employees reported a new round of job cuts across several parts of the company on Tuesday. A…
Redmond breaks ground on youth mental health facility | Redmond News
REDMOND, Ore. — Central Oregon families who have had to travel over the mountain for their children’s mental…
ChatGPT Writes Weaker Emails for Women, New Research Shows
Ask a chatbot to write the same kind of work email in two different ways, and you may…
Engineer’s Viral Post Captures the Soul-Crushing Downside of AI Coding
A software engineer’s viral post about AI coding has set off a debate over whether the technology is…
Meta’s TV Muse Ad Is the Latest Sign That Agents Are Going Mainstream
The next shiny new AI thing has arrived: The personal AI agent. Once mostly the domain of Silicon…
Pulley Shuts Down, Carta Helps Transition Customers
Pulley, a software that startups rely on to track their funding, is shutting down after seven years. The…
A Developer Asked Claude Code’s Creator About AI Slop. He Replied.
Developers are worried about AI. The creator of Claude Code has a response. On Thursday, Anthropic’s Boris Cherny…
Study finds KSM-66 ashwagandha root extract safe in sample of more than 1,000 adults
Published in Phytotherapy Research, the randomized, double-blind, placebo-controlled trial involved 1,002 adults and concluded Ixoreal Biomed Inc’s KSM-66…